News About <![CDATA[BIOGEN IDEC Inc.]]> News About en-us <![CDATA[Quintiles y Biogen Idec Anuncian Asociación Integral de Desarrollo Clínico]]> <![CDATA[Market Wrap For April 24: Apple's Smashing Earnings Overshadowed By Ukraine Concerns]]> U.S. stocks inched higher as Apple's strong earnings reported on Wednesday proved to be not enough to ease fears over an ...

]]>
<![CDATA[Thursday Sector Laggards: Healthcare, Industrial]]> <![CDATA[Quintiles (Q), Biogen (BIIB) Enter Five-Year Strategic Agreement]]> <![CDATA[Quintiles, Biogen Idec Announce Comprehensive Clinical Development Partnership]]> Quintiles, the world's largest provider of biopharmaceutical development and commercial outsourcing services, and Biogen Idec (NASDAQ: ...

]]>
<![CDATA[Quintiles and Biogen Idec Announce Comprehensive Clinical Development Partnership]]> <![CDATA[Will Today Be the Day the Dow Finally Does It?]]> ]]> <![CDATA[US STOCKS-Wall St snaps six-day run; Apple to split stock]]> <![CDATA[Market Wrap For April 23: S&P 500 Ends Winning Streak, Apple Announces 7-for-1 Stock Split]]> U.S. stocks fell after the S&P 500 and Nasdaq has risen for six consecutive trading sessions after new home sales data came in ...

]]>
<![CDATA[US STOCKS-Wall St slips to snap six-day rally; biotechs weak]]> <![CDATA[US STOCKS-Wall St slips after six-day S&P run; biotechs drop]]> <![CDATA[Biogen Idec (BIIB) Being Probed by Government Regarding Promotions]]> <![CDATA[Midday movers: Facebook, Gilead Sciences & More]]> <![CDATA[US STOCKS-Wall St edges down after six-day S&P rally; AT&T falls]]> <![CDATA[PBE, BIIB, ALXN, PCYC: Large Outflows Detected at ETF]]> <![CDATA[Interesting BIIB Put And Call Options For June 21st]]> <![CDATA[Interesting BIIB Put And Call Options For June 21st]]> <![CDATA[US STOCKS-Wall St edges lower following six-day S&P rally]]> <![CDATA[Stocks open mostly lower after recent rise; Boeing up on earnings]]> <![CDATA[UPDATE 2-Biogen raises outlook as new MS drug again tops forecasts]]> <![CDATA[5 Stories to Watch Before the Stock Market Opens Today]]>

U.S. stocks jumped yesterday on strong earnings reports and a deal frenzy across the healthcare sector. The S&P 500 and Nasdaq were in the black for the sixth consecutive trading session.

They'll go for seven on yet another big day of earnings reports.

The post 5 Stories to Watch Before the Stock Market Opens Today appeared first on Money Morning - Only the News You Can Profit From.

]]>
<![CDATA[Biogen posts higher profit as new MS drug again tops forecasts]]> <![CDATA[Biogen Idec, Inc. (BIIB) Misses Q1 EPS by 9c; Boosts FY14 Outlook]]> <![CDATA[Biogen Idec First Quarter 2014 Revenues Reach $2.1 Billion Driven by Continued Strength of MS Franchise]]> <![CDATA[Earnings Scheduled For April 23, 2014]]> The Procter & Gamble Company (NYSE: PG) is estimated to report its Q3 earnings at $1.02 per share on revenue of $20.68 billion.

Apple ...

]]>
<![CDATA[Market shift could drive further advance: Cramer]]> <![CDATA[Trading Radar for 04/23: Apple (AAPL), Facebook (FB), TI (TXN), Zynga (ZYNGA), Boeing (BA) Report]]> <![CDATA[US stocks open slightly higher amid M&A and earnings]]> <![CDATA[Apple, Microsoft are not the keys to this week’s news]]> <![CDATA[US STOCKS-Wall St advances; S&P, Nasdaq book fifth straight gain]]> <![CDATA[US STOCKS-Wall St rises modestly as investors eye earnings]]> <![CDATA[Biogen Idec Inc (BIIB): Planning An April Pivot Trade]]> Related posts:
  1. Biogen Idec Inc(BIIB): Biotech, Banks Look Best on Market Dip
  2. Setting Up A Winning Investment Strategy [Biogen Idec Inc(NASDAQ:BIIB)]
  3. Key Market News You Can Trade Off [Endocyte, Inc., Merck & Co., Inc., Biogen Idec Inc, Alexion Pharmaceuticals, Inc.]
  4. Can The Rally Continue In Biotech? [Alexion Pharmaceuticals, Inc., Biogen Idec Inc, Amgen, Inc.]
  5. Can Biotech Repeat In 2014? [Gilead Sciences, Inc., Biogen Idec Inc, Celgene Corporation]
]]>
<![CDATA[Can Gilead's Sovaldi rescue biotech?]]> <![CDATA[US STOCKS-Wall St edges higher, investors look to earnings]]> <![CDATA[US STOCKS-Wall St flat as investors await earnings]]> <![CDATA[Stocks edge higher as Wall Street awaits earnings blitz]]> <![CDATA[US STOCKS-Futures flat as investors await earnings onslaught]]> <![CDATA[Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII; Amunix Could Recieve up to $39M]]> Amunix Operating Inc. announced today that Biogen Idec (NASDAQ: BIIB) has exercised its option to enter into an exclusive, worldwide ...

]]>
<![CDATA[Company Update (NASDAQ:BIIB): Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII]]> [Marketwired] – Amunix Operating Inc. announced today that Biogen Idec has exercised its option to enter into an exclusive, worldwide license agreement to research and develop novel, fully-recombinant Factor VIII products … Read . . . → Read More: Company Update (NASDAQ:BIIB): Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII ]]> <![CDATA[Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII ]]> <![CDATA[US STOCKS-Futures edge up as investors await earnings onslaught]]> <![CDATA[Weekly Wrap-Up + Market Forecast + Sector Watch: SPX, Nasdaq, GLD, FAS, SOXX, FDN, AAPL, NFLX, GS, PNC, STT, V, QCOM, BRCM, XLNX, TXN, CELG, BIIB]]> <![CDATA[RPT-Wall St Week Ahead-Spring fever brings hope for U.S. earnings]]> <![CDATA[Long view on stocks is best during weak earnings season]]> <![CDATA[RPT-Wall St Week Ahead-Spring fever brings hope for U.S. earnings]]> <![CDATA[Wall St Week Ahead-Spring fever brings hope for U.S. earnings]]> <![CDATA[Here's what will drive stocks next week]]> <![CDATA[RBCC Bioprinting Partner Expands Brand Awareness Campaign]]> <![CDATA[Stocks Choppy With Escalation of Ukraine Violence]]> <![CDATA[U.S. healthcare usage and spending resumes rise in 2013 -report]]>